{"name":"Mateon Therapeutics","slug":"mateon-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOZmJEeS1EbndQWGpSczlMd0Q2dlB3QkJDWUVtaG1nT2ZXUHZ3TUoyR1BGTHctN2lMblNPWk9ITmdGR1hFRXhqcXFPd2pteXA0ajQwOHQ3M1lWcGpvcnpDcV9ZbGx6bEREOWc2cjBQSVRsTHZGZEI5bmxjSHdOTHdYVm13X1VRSHFFa0FobXFTQzNDN25iQkFpUmxwNV9xdw?oc=5","date":"2026-03-20","type":"pipeline","source":"openPR.com","summary":"High-Grade Glioma Treatment Pipeline Shows Strong Momentum as - openPR.com","headline":"High-Grade Glioma Treatment Pipeline Shows Strong Momentum as","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOMDN5bHVLdWR0b2hEZW84QkJNRU5DcVNuU1FuMkNZVWhuZ1lXQlVtMVpKSzQzUlJBT3FoOE1DT3ljb0MwajRCUlI3NUxoLVZkWVNLenMtcUNob1Ruc09oMzBnaTNEOFdvR1U5akgwVjQzNW54OGowYzV4R0ZYQlBrZ3VaY2dVN0lfVHd4UUlId01zNFNU0gGaAUFVX3lxTE9sV3laZFMwMm9UWFZ0eEM4RWlsRzNNY2VCZTBQbXI3UHVpckZtYkRJQ3pNUXRkRE5FOVVCbnhwanN4dEdtMUh3QjVhSERwX2djNnV6bHdJazlUT0xtSDA1Qkw0VWJsYWVSQTJjbl85UEd4dFJmalllU2tCdG5zX1ktVjQtcTdjdkU0eGVvQnNtZXRaUlhWLWQ5eUE?oc=5","date":"2021-03-06","type":"pipeline","source":"Express Pharma","summary":"Encourage members to adopt IPDMS: NPPA to pharma associations - Express Pharma","headline":"Encourage members to adopt IPDMS: NPPA to pharma associations","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2021-03-05","type":"pipeline","source":"Express Pharma","summary":"Windlas Biotech, Mateon Therapeutics launch drug-device plus lung therapy platform - Express Pharma","headline":"Windlas Biotech, Mateon Therapeutics launch drug-device plus lung therapy platform","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPa0t6SmhQdjRPTW5lX1R3eGxiVGhaREtueTA2YzgyWFR5UUpaR2ttZXY0NktjdDNIY2JFNEQtWlhEUjhRVjN2THV6MjZ1WkR3cUVOcW5XcmJ4djVlekhwVnF1TzhzTnFsMGs1b2R5NmIzdllTb0E1dGYtbEItTGhaTGs3ckVBMzlXTEVOMFZwQUgtdVFLOWlrSGpLN1dVdXFaUmRkVzNwMkZNaG5Uc1pRbzdMVGxLOTR1a01Xdlg0SF9BTXM?oc=5","date":"2021-02-23","type":"pipeline","source":"FFOODS Spectrum","summary":"Windlas Biotech, Mateon Therapeutics bring lung therapy food supplement PulmoHeal - FFOODS Spectrum","headline":"Windlas Biotech, Mateon Therapeutics bring lung therapy food supplement PulmoHeal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxOTWJrRlZZREk4WE5hMEdodFpZX0NnMV9IYzVRZWpKd1dQSnVvV3o3NEhiWVUzNE4tdUV6bUcyOXBWUnVGS1hjQjI4MXhuUVBFNUViUm1PcXgzWHM3ZG9BeU5aWUt6Z1FKX2Z5YmM2OEI5c2tqRTdSLWtYQWE0amlFV1AwN29aOGdwaFg4c3p2S3Vhd9IBlwFBVV95cUxPN1JNbTlsajB0UEUzNHBPRHZETG1LX1diMVYzaXktMnhwM2NDazlBaG8tdThWbG5WUlMyM3lEbGczWFpSX2hyd0daNk4wVXdxOWdiaW5rVnkwR08zQVAtU0xJa0tEbXBkQkl5b19sYTJzZ3A1amxiUW1neWtHTFZPN2h5Y2tDSW9HWmtoY04xemdsbTZvbERN?oc=5","date":"2021-02-22","type":"regulatory","source":"Express Pharma","summary":"Vivimed Labs gets approval for one product from Uzbekistan - Express Pharma","headline":"Vivimed Labs gets approval for one product from Uzbekistan","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMilgJBVV95cUxOWXh6cjBQN0V3QmRlaGFoWDJPVU5wN0RnTG9FanhZOU8wWXZtN2ZvQW02eUg2VXNILXRaMVM4eUJWZHBfdXlVUDV3U0Q4cHdFNGRMYmlVdVZTMmtyeDhDWTItdFF4Q0RQTVNJdlNJaE9xMHV4dmhEWnNyRTFKX0tDeHZZYllmclNCam1LNXlLVnpJTEJiNFhWeEt3dWh2dkVYcDMyejhJTEh3SDFUUkRLa2sxMXdnajlqREhKdFF6bS05Y250T3B1UHZ6UjVuRTFFRU8yV29HZW5NcmxJSFdjNGdmbkw0WDY0WnNKYUxZbW1jYUdlRXFXV1lhbWhSUU53bl9KR21SUm1jd0Fwblg1cXdUMlpaZw?oc=5","date":"2020-09-10","type":"trial","source":"The ASCO Post","summary":"Updated Data From PRIMA Trial: Niraparib as First-Line Maintenance Therapy for Advanced Ovarian Cancer - The ASCO Post","headline":"Updated Data From PRIMA Trial: Niraparib as First-Line Maintenance Therapy for Advanced Ovarian Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxOdGdZOEFzM21BbVltSDZQZGo3azA2cDRHNU5SUDNtVE14cVprVG0yRGNlTnVhRmE2cG1xMFpNVVNLR0RXM2dmck9XdnRXNHkzcnlGd280NEhXVGw3cm1WUFVvdm83XzJUMGY1NWpGd3NNeXlQYUVvdWs0Zm4zVUg1aDA2eEVCMmpaVVZNWkRmWW52UTNLcVdCWXRCVksxY0pNa0t5ZjctVHo4QmZXMkI2ZjR6dHpXbnFZbnUtMEREUG53bXF5Vm9SQ1FVUQ?oc=5","date":"2020-06-22","type":"pipeline","source":"globenewswire.com","summary":"Mateon and GMP Completed Research and Service Agreement - globenewswire.com","headline":"Mateon and GMP Completed Research and Service Agreement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE4tc0lzNEtxVGo5LVRJcHlDQXlMY254SmViM053SUxYSnkxQ2dZcjVFa3R0eGpQWFEyUWtzTGtnYXRERTlBcE90MUU1THFWZnc3dDkwbnlPN2JDb0Y2blYxQmdn?oc=5","date":"2020-05-18","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"Mateon Therapeutics - Genetic Engineering and Biotechnology News","headline":"Mateon Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQWnRkdVFxWE9YQzkwYkw0bXAzSWJ3YUpINkxQeXl0ZjJpUlFXZVZBcDE0Q3hMaERWakpzQ20xRUtsTWxxQUJVeHVBUENGaFN2V0tQdDExQnAwU19xck9xOWc1WWlvQmpPOHc5Zjc5cGpkOUVtZFhjUjg1bmZzblR2Y3lYS2Q3cUxVd2Vv?oc=5","date":"2020-03-03","type":"pipeline","source":"Pharmaceutical Technology","summary":"Mateon launches antiviral programme focussed on Covid-19 - Pharmaceutical Technology","headline":"Mateon launches antiviral programme focussed on Covid-19","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQS0RLaXB6QzVtZUlTcFlpZUJUa1JGWlplQ01nMk5ya201eWtKXy0yTE1sTUcyUVBpSF9raDFaWE93UVJ0UElCa3lEVVV3eEJoV0Y2dFJYM0Y2Z1lxX1MwRlhTUUEzMlo3cFVQYjhkZWxJN0lTWVBHeXhpLVFUNmlGenYzNUdzT2t3a0E?oc=5","date":"2018-01-03","type":"trial","source":"Genetic Engineering and Biotechnology News","summary":"Unlucky 13: Top Clinical Trial Failures of 2017 - Genetic Engineering and Biotechnology News","headline":"Unlucky 13: Top Clinical Trial Failures of 2017","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPdG9rLVpxaUgwRHU1enFRWlJCa1FHRlZVMkZ6Z1VhdDJSX1lCVzF1X3oyb2xrRzVwcGJfeEo3bDFMcFVXb1dUclpQMUFvZnNNN1VnRjhHMTNUME83SkNHTEI0eXdvVzVLeGpTMHJnYUx0eF9wUDdrVVFnOFpOLVFmOWlLVjFUSDR6ZEMxTWxkV3VRMDlKSDdxTUZvT3d6NG9EMmFCZFV0aF9jREhvLU4yeEczRHZ4dVRiYnhxbHpRdGQ?oc=5","date":"2016-06-17","type":"pipeline","source":"globenewswire.com","summary":"OXiGENE Announces Name Change to Mateon Therapeutics - globenewswire.com","headline":"OXiGENE Announces Name Change to Mateon Therapeutics","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}